Clinical Trial of Apomorphine Subcutaneous Infusion in Patients With Advanced Parkinson's Disease
Status:
Completed
Trial end date:
2017-06-08
Target enrollment:
Participant gender:
Summary
The primary objective of the trial was to investigate the efficacy of apomorphine continuous
subcutaneous infusion compared to placebo in Parkinson's Disease patients with motor
fluctuations not well controlled on medical treatment.
The secondary objective of the study was to investigate the safety and tolerability of
apomorphine continuous subcutaneous therapy.